Insider Selling: Healthways, Inc. (NASDAQ:TVTY) Director Sells $66,325,000.00 in Stock
Healthways, Inc. (NASDAQ:TVTY) Director Conan Laughlin sold 1,750,000 shares of the stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $37.90, for a total transaction of $66,325,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Healthways, Inc. (NASDAQ:TVTY) opened at 38.775 on Friday. The company has a 50-day moving average of $39.24 and a 200-day moving average of $31.87. The firm has a market capitalization of $1.53 billion, a price-to-earnings ratio of 17.466 and a beta of 0.37. Healthways, Inc. has a 1-year low of $16.04 and a 1-year high of $41.55.
Healthways (NASDAQ:TVTY) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.41 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.03. Healthways had a net margin of 17.30% and a return on equity of 29.81%. The business had revenue of $138.90 million for the quarter, compared to the consensus estimate of $138.15 million. Healthways’s revenue for the quarter was up 11.1% compared to the same quarter last year. On average, equities analysts predict that Healthways, Inc. will post $1.52 earnings per share for the current year.
Several institutional investors have recently added to or reduced their stakes in TVTY. State of Alaska Department of Revenue bought a new stake in Healthways during the first quarter worth about $107,000. ClariVest Asset Management LLC bought a new stake in Healthways during the first quarter worth about $141,000. US Bancorp DE bought a new stake in Healthways during the first quarter worth about $145,000. Strs Ohio bought a new stake in Healthways during the first quarter worth about $154,000. Finally, Capstone Asset Management Co. bought a new stake in Healthways during the first quarter worth about $216,000.
Several research analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Healthways from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research note on Tuesday, May 2nd. Oppenheimer Holdings, Inc. restated an “outperform” rating and set a $41.00 price target (up previously from $32.00) on shares of Healthways in a research note on Monday, May 1st. Jefferies Group LLC reiterated a “buy” rating and issued a $36.00 target price (up from $33.00) on shares of Healthways in a research note on Saturday, April 29th. Cantor Fitzgerald reiterated a “buy” rating and issued a $34.00 target price on shares of Healthways in a research note on Friday, April 28th. Finally, ValuEngine upgraded shares of Healthways from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Two investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $35.25.
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.